Atovaquone:Susc:Pt:Isolate:OrdQn:MIC

Known as: Atovakoon:Susc:Pt:Is:OrdQn:MIK, Atovaquone [Susceptibility] by Minimum inhibitory concentration (MIC), ????:??????:???:???:???????:??????? 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1998-2018
01219982018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
The recent advances in next-generation sequencing technologies provide a new and effective way of tracking malaria drug-resistant… (More)
Is this relevant?
2016
2016
The rapid emergence of drug-resistant malaria parasites during the course of an infection remains a major challenge for providing… (More)
  • figure 1
Is this relevant?
2015
2015
The cytochrome bc1 complex (cyt bc1) is the third component of the mitochondrial electron transport chain and is the target of… (More)
  • table 1
  • table 2
  • figure 1
  • table 3
  • table 4
Is this relevant?
2011
2011
Toxoplasmic encephalitis (TE) is the most common clinical manifestation of reactivated infection with Toxoplasma gondii in… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2008
2008
Sulfadiazine, pyrimethamine, and atovaquone are widely used for the treatment of severe toxoplasmosis. Their in vitro activities… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2006
2006
Fourteen ferrocenyl aminohydroxynaphthoquinones, analogues of atovaquone, were synthesized from the hydroxynaphthoquinone core… (More)
Is this relevant?
2004
2004
Atovaquone-proguanil has been shown to be effective and well tolerated for malaria prophylaxis in residents of countries of… (More)
Is this relevant?
2003
2003
Clinical treatment failures of the hydroxynaphthoquinone atovaquone or its combination with proguanil (Malarone) in Plasmodium… (More)
Is this relevant?
2003
2003
Pregnant women are particularly vulnerable to malaria infections. Multidrug resistance in Plasmodium falciparum seriously… (More)
Is this relevant?
2000
2000
In endemic zones, the atovaquone-proguanil (AP) combination is well tolerated and effective in treating acute, uncomplicated… (More)
Is this relevant?